Smartphone Delivered In-home Cardiopulmonary Rehabilitation
2 other identifiers
interventional
258
1 country
1
Brief Summary
The goal of this study is to determine if a remote cardiac or pulmonary rehabilitation program delivered via a smartphone application and regular telephone calls will lead to improved delivery of cardiac rehabilitation compared to usual care. This includes increased adherence for eligible veterans, increased program completion, improved patient outcomes as measured by functional capacity, improved patient compliance in monitoring symptoms, improved self-efficacy and knowledge in managing disease and, a decreased rate of hospitalization and re-admissions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2016
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2016
CompletedFirst Submitted
Initial submission to the registry
June 2, 2016
CompletedFirst Posted
Study publicly available on registry
June 7, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 3, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 3, 2022
CompletedJanuary 29, 2026
January 1, 2026
5.8 years
June 2, 2016
January 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Functional Capacity assessed by the Six Minute Walk Test (6MWT)
The six-minute walk test (6MWT) measures the distance an individual is able to walk over a total of six minutes on a hard, flat surface. The goal is for the individual to walk as far as possible in six minutes. The individual is allowed to self-pace and rest as needed as they traverse back and forth along a marked walkway.
Week 12, Week 24
Secondary Outcomes (8)
Change in Measure of Exercise Intensity (MET)
Baseline, Week 12
Change in Weight
Baseline, Week 12
Change in Body Mass Index (BMI)
Baseline, Week 12
Change in Blood Pressure
Baseline, Week 12
Change in A1c Level
Baseline, Week 12
- +3 more secondary outcomes
Study Arms (3)
Cardiac Rehabilitation - Movn Program
EXPERIMENTALParticipants with coronary artery disease (CAD) and chronic obstructive pulmonary disease (COPD) who are eligible for cardiac rehabilitation will undergo an in-home program.
Pulmonary Rehabilitation - Movn Program
EXPERIMENTALParticipants with stable chronic obstructive pulmonary disease (COPD) or hospitalized with an acute exacerbation of COPD will undergo an in-home pulmonary rehabilitation program.
Traditional Cardiac Rehabilitation
ACTIVE COMPARATORParticipants enrolled in a facility's traditional cardiac rehabilitation program will be seen at baseline and during a 12 and 24 week follow-up visit.
Interventions
Movn pulmonary rehabilitation is a program delivered by the Movn smartphone application that includes targeted educational content and prescribed exercises with mild resistance training in addition to walking and other cardiovascular exercises. The application will track activity using a built-in accelerometer or through connected devices such as a Fitbit for daily physical activity and management. Weight and blood pressure (BP) will be tracked by manual input or through wireless scales and BP monitors. The program will last for 12 weeks.
Standard cardiac rehabilitation involves a facility's standard rehabilitation practices. Participants will be seen at baseline and during a 12 and 24 week follow-up visit.
MULTIFIT is a cardiac rehabilitation program delivered by the Movn smartphone application that will provide risk factor modification, prescribed exercises, education and counseling. The application will track activity using a built-in accelerometer or through connected devices such as a Fitbit for daily physical activity and management. Weight and blood pressure (BP) will be tracked by manual input or through wireless scales and BP monitors. The program will last for 12 weeks.
Eligibility Criteria
You may qualify if:
- Meet eligibility for cardiac rehabilitation program as defined by Centers for Medicare \& Medicaid Services (CMS); they may also have stable CAD and be referred for cardiac rehab by their provider.
- Following acute myocardial infarction (within the preceding 12 months)
- Coronary artery bypass grafting (CABG)
- Current stable angina pectoris
- Heart valve repair or replacement
- Percutaneous transluminal coronary angioplasty (PTCA) or coronary stenting
- Heart or heart-lung transplant
- Other diagnosis by specific physician referral
You may not qualify if:
- Unstable angina
- Resting systolic blood pressure \>200 mm Hg or resting diastolic blood pressure \>110 mm Hg
- Significant drop (\>=20 mm Hg) in resting systolic blood pressure from the patient's average level that cannot be explained by medications
- Moderate to severe aortic stenosis
- Acute systemic illness or fever
- Uncontrolled atrial or ventricular arrhythmias
- Symptomatic congestive heart failure (stage C)
- Third-degree heart block without pacemaker
- Active pericarditis or myocarditis
- Recent venous thromboembolism (VTE, as determined by physician)
- Current Thrombophlebitis
- Uncontrolled diabetes (A1c \> 7.0 or as determined by physician)
- Orthopedic problems that would prohibit exercise
- Other by specific physician instruction
- Peripheral vascular disease (PVD; symptomatic or that would prohibit exercise)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Emory Universitylead
- Atlanta VA Medical Centercollaborator
Study Sites (1)
Atlanta VA Medical Center
Atlanta, Georgia, 30033, United States
Related Publications (2)
Harzand A, Alrohaibani A, Idris MY, Spence H, Parrish CG, Rout PK, Nazar R, Davis-Watts ML, Wright PP, Vakili AA, Abdelhamid S, Vathsangam H, Adesanya A, Park LG, Whooley MA, Wenger NK, Zafari AM, Shah AJ. Effects of a patient-centered digital health intervention in patients referred to cardiac rehabilitation: the Smart HEART clinical trial. BMC Cardiovasc Disord. 2023 Sep 12;23(1):453. doi: 10.1186/s12872-023-03471-w.
PMID: 37700245DERIVEDHarzand A, Witbrodt B, Davis-Watts ML, Alrohaibani A, Goese D, Wenger NK, Shah AJ, Zafari AM. Feasibility of a Smartphone-enabled Cardiac Rehabilitation Program in Male Veterans With Previous Clinical Evidence of Coronary Heart Disease. Am J Cardiol. 2018 Nov 1;122(9):1471-1476. doi: 10.1016/j.amjcard.2018.07.028. Epub 2018 Aug 4.
PMID: 30217377DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Amit J Shah, MD
Emory University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
June 2, 2016
First Posted
June 7, 2016
Study Start
May 1, 2016
Primary Completion
March 3, 2022
Study Completion
March 3, 2022
Last Updated
January 29, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share